ETFs & Funds
FDA wants more studies on long-term effect. Will $
hold its price anywhere near $1.90?
Ended at $1.35 AH. IMO should rebound in next few days when people understand reality of CRL.
More studies cost more $. Secondary coming.
Add a reply...
Latest StockTalks »
people get DRRX breaking news and analysis by email alert.
Get email alerts on DRRX »
Get latest price
From other sites
The Wall Street Journal: Pfizer ends agreement to develop Remoxy
at MarketWatch.com (Oct 27, 2014)
Movers & Shakers: Thursday movers: Pulte, Lennar sink in market rout
at MarketWatch.com (Jun 20, 2013)
Movers & Shakers: Friday’s biggest gaining and declining stocks
at MarketWatch.com (Jan 6, 2012)
Stocks on the Move Now
at CNBC.com (Jan 6, 2012)
Biotech Stocks: Icagen rallies as drug stocks head north
at MarketWatch.com (Jun 27, 2011)